p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and FOXP1
Status PubMed-not-MEDLINE Language English Country United States Media electronic-ecollection
Document type Editorial
PubMed
30559925
PubMed Central
PMC6284860
DOI
10.18632/oncotarget.26376
PII: 26376
Knihovny.cz E-resources
- Keywords
- BCR signalling, CD22, DNA damage, miR-34a, phosphatase,
- Publication type
- Editorial MeSH
See more in PubMed
Devan J, et al. Semin Oncol. 2018. Oct 22, https://doi.org/10.1053/j.seminoncol.2018.07.005 . [Epub ahead of print] DOI
Mraz M, et al. Blood. 2014;124:84–95. PubMed PMC
Musilova K, et al. Blood. 2018. Sep 13, https://doi.org/10.1182/blood-2018-06-855502 . [Epub ahead of print] DOI
Cui B, et al. Blood. 2014;124:546–54. PubMed PMC
Cerna K, et al. Leukemia. 2018. Aug 15, https://doi.org/10.1038/s41375-018-0230-x . [Epub ahead of print] DOI
Gascoyne DM. Leuk Lymphoma. 2017;58:1037–51. PubMed
Psathas JN, et al. Blood. 2013;122:4220–9. PubMed PMC
Olive V, et al. Genes Dev. 2009;23:2839–49. PubMed PMC
Musilova K. Leukemia. 2015;29:1004–17. PubMed
Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies
